Public, NASDAQ:ACUR
NASDAQ Capital Market
Russell tanks 7%; FNDT, ACUR and MYRG lead gainers
Date: Fri, 14 Nov 2008 22:26:14 GMT
Tags:
Russell tanks 7%; FNDT, ACUR and MYRG lead gainers
SmallCapInvestor - Nov 14, 2008
SmallCapInvestor - Nov 14, 2008
Small-cap stocks threw a gasket in the final hour of trading Friday, giving back a lion’s share of Thursday’s stunning rally off new bear market lows while finishing with the lowest weekly close ...
Acura Pharmaceuticals, Inc. Reports Third Quarter 2008 Financial Results
Date: Mon, 27 Oct 2008 21:27:49 GMT
Tags:
Acura Pharmaceuticals, Inc. Reports Third Quarter 2008 Financial Results
CNNMoney.com (press release) - Oct 27, 2008
CNNMoney.com (press release) - Oct 27, 2008
PALATINE, Ill., Oct. 27, 2008 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (Nasdaq:ACUR) today reported 2008 third quarter net income of $3.1 million, or $0.06 per diluted share compared to a ...
Drug for Pain ‘Significantly Disliked’ in Excess Doses, Company Says
Date: Tue, 14 Oct 2008 21:15:32 GMT
Tags:
Drug for Pain ‘Significantly Disliked’ in Excess Doses, Company Says
FDA news (subscription) - Oct 14, 2008
FDA news (subscription) - Oct 14, 2008
A Phase II study testing Acura Pharmaceuticals and King Pharmaceuticals’ Acurox tablets for pain treatment showed positive outcomes. The companies are developing the drug to treat moderate-to ...
ACUR: To Present At Natixis Hidden Gems Conference @ 15:00 ET [delayed]
Date: Mon, 13 Oct 2008 17:28:40 GMT
Tags:
ACUR: To Present At Natixis Hidden Gems Conference @ 15:00 ET [delayed]
Trading Markets (press release) - Oct 13, 2008
Trading Markets (press release) - Oct 13, 2008
Ridgeland, MS, OCT 13, 2008 (EventX/Knobias.com via COMTEX) -- NTXFF | Quote | Chart | News | PowerRating -- Company representatives of Acura Pharmaceuticals, Inc. (NasdaqSC: ACUR | Quote | Chart ...
Acura Pharma, King Pharma say study assessing abuse liability shows Acurox tablets disliked when excess doses are swallowed - Update
Date: Mon, 13 Oct 2008 13:27:48 GMT
Tags:
Acura Pharma, King Pharma say study assessing abuse liability shows Acurox tablets disliked when excess doses are swallowed - Update
RTT News - Oct 13, 2008
RTT News - Oct 13, 2008
(RTTNews) - Monday, Acura Pharmaceuticals Inc. (ACUR: News ) and King Pharmaceuticals, Inc. (KG) said results from study AP-ADF-111, or Study 111, demonstrated that Acurox tablets are disliked ...
A 1-in-100 Investor (at Motley Fool)
Date: Wed, 19 Nov 2008 19:16:17 Etc/GMT
Tags:
Russell tanks 7%; FNDT, ACUR and MYRG lead gainers (SmallCapInvestor.com)
Date: Fri, 14 Nov 2008 22:02:05 Etc/GMT
Tags:
Small caps finished with the lowest weekly close since August 2003.
Five-year weekly closing low for Russell as techs slump, retailers swoon (SmallCapInvestor.com)
Date: Fri, 14 Nov 2008 21:28:01 Etc/GMT
Tags:
ACURA PHARMACEUTICALS, INC Financials (EDGAR Online Financials)
Date: Fri, 31 Oct 2008 13:04:13 Etc/GMT
Tags:
Acura Pharmaceuticals, Inc. Reports Third Quarter 2008 Financial Results (GlobeNewswire)
Date: Mon, 27 Oct 2008 21:19:37 Etc/GMT
Tags:
PALATINE, Ill., Oct. 27, 2008 -- Acura Pharmaceuticals, Inc. today reported 2008 third quarter net income of $3.1 million, or $0.06 per diluted share compared to a net loss of $2.5 million, or a loss per share for the same quarter in 2007.